Phase 1 trial of excretion of radioactivity, metabolic profiles and PK following oral [14C] SP-420

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  1009954

• Contact name

  Peter Bubak

• Contact email

  pbu@pharmacosmos.com

• Sponsor organisation

  Publication of this data is currently deferred.

• ISRCTN Number

  ISRCTN22812347

• Research summary

  Publication of this data is currently deferred.

• REC name

  North East - York Research Ethics Committee

• REC reference

  24/NE/0138

• Date of REC Opinion

  12 Nov 2024

• REC opinion

  Further Information Favourable Opinion